Skinvisible, Inc.
SKVI
$0.25
-$0.05-16.67%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | -42.58% | -14.60% | -4.69% | 13.28% | 45.25% |
| Depreciation & Amortization | 0.00% | -13.56% | 6.25% | 4.26% | 8.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.48% | -14.54% | -4.40% | 13.03% | 43.96% |
| Operating Income | 42.53% | 15.12% | 4.56% | -13.56% | -45.57% |
| Income Before Tax | -182.08% | 12.70% | 9.56% | 3.24% | 203.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -182.08% | 12.70% | 9.56% | 3.24% | 203.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -182.08% | 12.70% | 9.56% | 3.24% | 203.62% |
| EBIT | 42.53% | 15.12% | 4.56% | -13.56% | -45.57% |
| EBITDA | 43.68% | 15.21% | 4.86% | -13.84% | -46.97% |
| EPS Basic | -200.63% | 26.62% | 23.95% | 18.13% | 171.00% |
| Normalized Basic EPS | -200.67% | 26.84% | 24.16% | 18.25% | 171.05% |
| EPS Diluted | -200.63% | 26.62% | 23.95% | 18.13% | 171.00% |
| Normalized Diluted EPS | -200.67% | 26.84% | 24.16% | 18.25% | 171.05% |
| Average Basic Shares Outstanding | -18.44% | 19.03% | 19.03% | 18.13% | 45.95% |
| Average Diluted Shares Outstanding | -18.44% | 19.03% | 19.03% | 18.13% | 45.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |